It is with great pleasure that Novartis Sverige AB would like to invite to a virtual meeting with Dr. Heather Shaw from the Mount Vernon Cancer Centre (Northwood, UK) and University College London Hospital (London, UK) as a speaker.
The overall meeting objective is to provide education about optimal patient management practices with focus on adjuvant treatment of malignant melanoma. Treatment decision rationale, as well as patient preparation and AE management will be discussed on an interactive clinical case session.
This virtual meeting is intended to HCPs (oncologists, specialized physicians and nurses) that treat malignant melanoma patients as part of their clinical routine.
Virtual meeting (Microsoft Teams)
Dr. Heather Shaw
Mount Vernon Cancer Centre and University College London Hospital (UK)
Dr. Gustav Ullenhag
Institute for Immunology, Genetics and Pathology
Akademiska sjukhuset (Uppsala, Sweden)